<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Sir William Dunn Sch of Pathology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/F7D643D0-62B2-49F2-86CC-48C63B571F0D"><gtr:id>F7D643D0-62B2-49F2-86CC-48C63B571F0D</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>John</gtr:otherNames><gtr:surname>Norbury</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FF013531%2F1"><gtr:id>B158EDFD-517E-40F7-9B65-71610EC91C02</gtr:id><gtr:title>RNA polyuridylation: regulation and consequences</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/F013531/1</gtr:grantReference><gtr:abstractText>While the DNA in our cells contains the information that controls their behaviour, this information has to be copied into RNA 'messages' before it can be decoded, for example to make proteins. The information content of each message, copied from the DNA template, is encoded in a long string of chemical letters, of which there are four types: A, U, C and G. For some time it has been known that the end of most RNA messages consists of a string of 'A' letters that are not encoded in the DNA, but added after the message has been copied. The length of this A-tail determines how long the message lasts before being destroyed, and how efficiently it is decoded to make protein. We have recently discovered that messages can instead have tails made mostly of 'U' letters, and that this is something that happens in organisms as distantly related as yeasts and humans. This project aims to investigate the function of these U-tails, and to determine how their synthesis is regulated. Our preliminary results suggest that, in the longer term, drugs that interfere with the addition of U-tails to RNAs might inhibit the growth of cancer cells.</gtr:abstractText><gtr:technicalSummary>Nuclear poly(A) polymerase (PAP) polyadenylates nascent mRNAs to promote their nuclear export, stability and translation, while the related cytoplasmic polymerase GLD-2 activates translation of de-adenylated mRNAs. We have recently characterized the biochemical activity of fission yeast Cid1, a cytoplasmic PAP/GLD-2-related enzyme implicated in cell cycle checkpoint controls. Surprisingly, while acting as a PAP in vitro, Cid1 has far more robust poly(U) polymerase (PUP) activity, especially when isolated in native multi-protein complexes. This PUP activity is conserved in human cells, where the Cid1-related protein Hs2 [ZCCHC6] shows similar nucleotide preferences. Our preliminary data indicate that mRNA polyuridylation occurs in vivo. The biochemical basis for the increased PUP versus PAP activity of purified Cid1 multi-protein complexes will be investigated by evaluating the contributions made by Cid1-interacting proteins, possible post-translational modifications and associated nuclease activities. Microarray hybridisation using oligo(dA)-primed cDNA will be used to identify polyuridylated RNAs in fission yeast and human cells, and the consequences of mRNA polyuridylation will be investigated using MS2 tethering and in vitro RNA degradation assays. Together, these studies will allow us to investigate the hypothesis that U-rich Cid1/Hs2-generated tails form the basis of a novel, conserved level of RNA regulation.</gtr:technicalSummary><gtr:fund><gtr:end>2011-01-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2008-02-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>303292</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The findings defined a previously unknown pathway of mRNA degradation. It has since transpired that similar mechanisms are used to regulate miRNA biogenesis.</gtr:description><gtr:firstYearOfImpact>2009</gtr:firstYearOfImpact><gtr:id>CBB6C5B7-B578-4C0B-8845-42362FE85DE9</gtr:id><gtr:impactTypes><gtr:impactType>Cultural</gtr:impactType></gtr:impactTypes><gtr:outcomeId>545241aabc5756.28733522</gtr:outcomeId><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>The findings defined a previously unknown pathway of mRNA degradation. It has since transpired that similar mechanisms are used to regulate miRNA biogenesis.</gtr:description><gtr:exploitationPathways>Therapeutic intervention in the pathway defined by our study may be of value in the treatment of cancers.</gtr:exploitationPathways><gtr:id>2D690178-C34F-4A12-8EFA-459809F56A9A</gtr:id><gtr:outcomeId>545242406ce8c3.94522271</gtr:outcomeId><gtr:sectors><gtr:sector>Healthcare,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors><gtr:url>http://users.ox.ac.uk/~path0204/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E2E3C5E3-91C8-414A-AED0-1874590758B2</gtr:id><gtr:title>Cytoplasmic RNA: a case of the tail wagging the dog.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Molecular cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f083e9f6f3e233feb9fd126c0c538579"><gtr:id>f083e9f6f3e233feb9fd126c0c538579</gtr:id><gtr:otherNames>Norbury CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-0072</gtr:issn><gtr:outcomeId>541ffaecd4c394.73423653</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E1B93FF-8E52-4266-8E46-DF9636F069E0</gtr:id><gtr:title>The Cid1 poly(U) polymerase.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d4ee7e2ce2d2d67f54aae91cda5afd7"><gtr:id>3d4ee7e2ce2d2d67f54aae91cda5afd7</gtr:id><gtr:otherNames>Rissland OS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>PwoigsvQcD4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4C534DEA-B64C-419F-BF96-AE1D610405C8</gtr:id><gtr:title>Regional specialization: the NEXT big thing in nuclear RNA turnover.</gtr:title><gtr:parentPublicationTitle>Molecular cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f083e9f6f3e233feb9fd126c0c538579"><gtr:id>f083e9f6f3e233feb9fd126c0c538579</gtr:id><gtr:otherNames>Norbury CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-2765</gtr:issn><gtr:outcomeId>pm_13473_23_21855790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4276487B-F6BF-4E8F-992F-2B72A6801C13</gtr:id><gtr:title>Decapping is preceded by 3' uridylation in a novel pathway of bulk mRNA turnover.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3d4ee7e2ce2d2d67f54aae91cda5afd7"><gtr:id>3d4ee7e2ce2d2d67f54aae91cda5afd7</gtr:id><gtr:otherNames>Rissland OS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>E74Nyj1nMDW</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A7A9E77-05A3-4BD3-9F59-9E66BB10FD3B</gtr:id><gtr:title>Telomere maintenance: all's well that ends well.</gtr:title><gtr:parentPublicationTitle>Archives of toxicology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d11c06f86e0d76c5e83a77a154a6d3b"><gtr:id>6d11c06f86e0d76c5e83a77a154a6d3b</gtr:id><gtr:otherNames>Liew LP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0340-5761</gtr:issn><gtr:outcomeId>pm_13473_13_19337721</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EA4EB243-C192-4857-9E83-3F569278C299</gtr:id><gtr:title>The human cytoplasmic RNA terminal U-transferase ZCCHC11 targets histone mRNAs for degradation.</gtr:title><gtr:parentPublicationTitle>RNA (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6466d0952e069b438d56a074ad959539"><gtr:id>6466d0952e069b438d56a074ad959539</gtr:id><gtr:otherNames>Schmidt MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1355-8382</gtr:issn><gtr:outcomeId>541ffaed5c5278.12034095</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5DB9FC70-4E31-49FF-A13B-17AD84BD8C69</gtr:id><gtr:title>Structural basis for the activity of a cytoplasmic RNA terminal uridylyl transferase.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/29f84b5dc87053e06e5c809f5df61328"><gtr:id>29f84b5dc87053e06e5c809f5df61328</gtr:id><gtr:otherNames>Yates LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>541ffaee14d706.93653052</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8A9090C9-DD63-4FFD-B3B9-5FB76C2F9470</gtr:id><gtr:title>Special issue: Novel RNA nucleotidyl transferases and gene regulation. Preface.</gtr:title><gtr:parentPublicationTitle>Biochimica et biophysica acta</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f083e9f6f3e233feb9fd126c0c538579"><gtr:id>f083e9f6f3e233feb9fd126c0c538579</gtr:id><gtr:otherNames>Norbury CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-3002</gtr:issn><gtr:outcomeId>pm_13473_13_18402915</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E838F248-ED9D-4E80-A014-0A1682CC036C</gtr:id><gtr:title>3' Uridylation and the regulation of RNA function in the cytoplasm.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f083e9f6f3e233feb9fd126c0c538579"><gtr:id>f083e9f6f3e233feb9fd126c0c538579</gtr:id><gtr:otherNames>Norbury CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>541ffaed922c72.67508897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DD7B771-4887-4560-A507-C6BE2B73DD27</gtr:id><gtr:title>Polyadenylation and beyond: emerging roles for noncanonical poly(A) polymerases.</gtr:title><gtr:parentPublicationTitle>Wiley interdisciplinary reviews. RNA</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6466d0952e069b438d56a074ad959539"><gtr:id>6466d0952e069b438d56a074ad959539</gtr:id><gtr:otherNames>Schmidt MJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1757-7004</gtr:issn><gtr:outcomeId>pm_13473_23_21956911</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/F013531/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>